Marshall Wace, LLP Elanco Animal Health Inc Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 167,823 shares of ELAN stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

167,823

Previous 398,499 57.89%

Holding current value

$1.87 Million

Previous $5.85 Million 65.26%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$11.63 - $14.67 $2.68 Million - $3.38 Million	-230,676 Reduced 57.89%	167,823 $2.03 Million
Q3 2024 Nov 14, 2024	SELL	$11.85 - $15.47 $11.7 Million - $15.3 Million	-986,616 Reduced 71.23%	398,499 $5.85 Million
Q2 2024 Aug 14, 2024	SELL	$12.93 - $18.45 $71.1 Million - $101 Million	-5,497,626 Reduced 79.88%	1,385,115 $20 Million
Q1 2024 May 15, 2024	BUY	$14.37 - $16.46 $76.2 Million - $87.3 Million	5,304,997 Added 336.24%	6,882,741 $112 Million
Q4 2023 Feb 14, 2024	BUY	$8.6 - $14.94 $11 Million - $19 Million	1,274,406 Added 420.13%	1,577,744 $23.5 Million
Q3 2023 Nov 14, 2023	SELL	$9.81 - $12.62 $27.4 Million - $35.2 Million	-2,793,029 Reduced 90.2%	303,338 $3.41 Million
Q2 2023 Aug 14, 2023	BUY	$8.08 - $10.37 $17.4 Million - $22.4 Million	2,158,367 Added 230.1%	3,096,367 $31.1 Million
Q1 2023 May 15, 2023	BUY	$8.79 - $14.58 $467,812 - $775,962	53,221 Added 6.02%	938,000 $8.82 Million
Q4 2022 Feb 14, 2023	BUY	$11.49 - $13.65 $2.93 Million - $3.48 Million	254,983 Added 40.49%	884,779 $10.8 Million
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $3.69 Million - $9.64 Million	297,263 Added 89.39%	629,796 $7.82 Million
Q2 2022 Aug 15, 2022	BUY	$19.63 - $26.62 $5.24 Million - $7.11 Million	267,098 Added 408.19%	332,533 $6.53 Million
Q1 2022 May 16, 2022	SELL	$24.65 - $29.0 $11.3 Million - $13.3 Million	-457,388 Reduced 87.48%	65,435 $1.71 Million
Q2 2021 Aug 13, 2021	BUY	$28.76 - $35.98 $12 Million - $15 Million	418,272 Added 400.07%	522,823 $18.1 Million
Q1 2021 May 17, 2021	BUY	$27.85 - $34.49 $1.71 Million - $2.12 Million	61,553 Added 143.15%	104,551 $3.08 Million
Q4 2020 Feb 16, 2021	BUY	$27.53 - $33.79 $1.18 Million - $1.45 Million	42,998 New	42,998 $1.32 Million
Q3 2020 Nov 16, 2020	SELL	$21.1 - $29.13 $3.4 Million - $4.69 Million	-160,979 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$18.94 - $24.93 $3.05 Million - $4.01 Million	160,979 New	160,979 $3.45 Million
Q1 2020 May 15, 2020	SELL	$16.68 - $32.25 $17.6 Million - $34 Million	-1,055,573 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$25.29 - $29.45 $11.8 Million - $13.7 Million	464,858 Added 78.69%	1,055,573 $31.1 Million
Q3 2019 Nov 14, 2019	BUY	$25.62 - $34.96 $8.39 Million - $11.4 Million	327,440 Added 124.37%	590,715 $15.7 Million
Q2 2019 Aug 14, 2019	BUY	$31.11 - $34.79 $8.19 Million - $9.16 Million	263,275 New	263,275 $8.9 Million

Others Institutions Holding ELAN

# of Institutions

438

Shares Held

448M

Call Options Held

1.16M

Put Options Held

1.12M

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.28B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Elanco Animal Health Inc Transaction History